Skip to main content
SpringerLink
Log in

The ART of preventing HIV

  • Community Corner
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grant, R.M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. published online, 10.1056/NEJMoa1011205 (23 November 2010).

  2. Karim, Q.A. et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168–1174, 2010.

    Google Scholar 

  3. Donnell, D. et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375, 2092–2098 (2010).

    Google Scholar 

  4. Gallant, J.E., Parish, M.A., Keruly, J.C. & Moore, R.D. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin. Infect. Dis. 40, 1194–1198 (2005).

    Google Scholar 

  5. Golub, S.A., Kowalczyk, W., Weinberger, C.L. & Parsons, J.T. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J. Acquir. Immune Defic. Syndr. 54, 548–555 (2010).

    Google Scholar 

  6. Mellors, J.W. Closing in on HIV-1: antiretroviral therapy back on track with HIV-1 protease inhibitors. Nat. Med. 2, 1–2 (1996).

    Google Scholar 

  7. Cohen, M.S., Hellmann, N., Levy, J.A., DeCock, K. & Lange, J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 118, 1244–1154 (2008).

    Google Scholar 

  8. Cohen, M.S., Gay, C., Kashuba, A.D., Blower, S. & Paxton, L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann. Intern. Med. 146, 591–601 (2007).

    Google Scholar 

  9. Garcia-Lerma, J.G. et al. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infect. Science Transl. Med. 13, 14ra4 (2010).

    Google Scholar 

Download references

Ethics declarations

Competing interests

S.G.D. has received research support from Gilead Sciences.

J.W.M. is a consultant to Gilead Sciences, Merck and RFS Pharma. He also holds share options in RFS Pharma, an early-stage biotech company that is developing new therapeutics for HIV and hepatitis C virus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

The ART of preventing HIV. Nat Med 17, 46–47 (2011). https://doi.org/10.1038/nm0111-46

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0111-46

  • Springer Nature America, Inc.

Search

Navigation